FET ends 2024 with COMPAMED success

COMPAMED 2024 attracts suppliers of a comprehensive range of high-quality medical technology components, services and production equipment for the medical industry.

Fibre Extrusion Technology (FET) of Leeds, UK enjoyed a highly successful exhibition at COMPAMED 2024 in Düsseldorf. This was the first time that FET had exhibited at this leading international trade fair for the medical technology supplier sector, a reflection of the company’s growing role in the global medical sector. In 2023-24, over 60 per cent of FET’s turnover was derived from the medical market.

“It is never certain whether a new exhibition will prove to be a successful venture until it is tested in practice” commented FET’s Managing Director Richard Slack, “but we are delighted to report that COMPAMED 2024 exceeded all expectations. In fact, we have already booked a stand for next year’s exhibition in November, albeit in a slightly different location.”

COMPAMED 2024 attracts suppliers of a comprehensive range of high-quality medical technology components, services and production equipment for the medical industry. FET’s expertise in this sector therefore proved to be a perfect fit. With almost 40 serious customer leads taken at the show from both existing and previously unidentified clients, the initial outlook is for a very successful exhibition which will be followed up by future participation at this annual event.

FET’s established expertise lies in laboratory and pilot melt spinning equipment for a vast range of applications, especially precursor materials used in high value medical devices and specialised novel fibres from exotic and difficult to process polymers. In cases where melt spinning solutions are not suitable, FET provides a viable alternative with pilot and small scale production wet spinning systems.